A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
William H. H. Reece(John Radcliffe Hospital), Adrian V. S. Hill(University of Oxford), Brian Greenwood(MRC Unit the Gambia), Peter Akinwunmi(MRC Unit the Gambia), Nadia Tornieporth(GlaxoSmithKline (United Kingdom)), Kalifa Bojang(MRC Unit the Gambia), Katherine R. Watkins(John Radcliffe Hospital), S. Everaere(John Radcliffe Hospital), Paul Milligan(MRC Unit the Gambia), Magdalena Plebanski(RMIT University), Philip Gothard(John Radcliffe Hospital), Ali Alloueche(London School of Hygiene & Tropical Medicine), Gérald Voss(TuBerculosis Vaccine Initiative), Kent E. Kester(Walter Reed Army Institute of Research), Tom Doherty(MRC Unit the Gambia), Keith P. W. J. McAdam(London School of Hygiene & Tropical Medicine), Margaret Pinder(MRC Unit the Gambia), Joe Cohen(GlaxoSmithKline (United Kingdom))
Cited by 266
Related Papers
Bulletin of the World Health Organization
|Bulletin of the World Health Organization|2001|7.2k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643